Viral safety studies of Flebogamma®, a pasteurized liquid intravenous immunoglobulin.

被引:0
|
作者
Biescas, H [1 ]
Ruiz, P [1 ]
Gajardo, R [1 ]
Massot, M [1 ]
Ristol, P [1 ]
Jorquera, JI [1 ]
机构
[1] Inst Grifols SA, Res & Dev Area, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4018
引用
收藏
页码:134B / 134B
页数:1
相关论文
共 50 条
  • [41] Evaluation of the efficacy and safety of Griflow® Dual, a pre-set two-flow infusion device for intravenous immunoglobulin (Flebogamma® 5%) administration
    Sanchez, Argentina
    Alvarez, Magdalena
    Adoracion Bustillo, Maria
    Carmen Garcia, Maria
    Munoz, Margarita
    Pacios, Concepcion
    Pizarroso, Lorena
    Isabel Rubio, Maria
    Rodriguez, Nuria
    JOURNAL OF VASCULAR ACCESS, 2012, 13 (01): : 101 - 107
  • [42] SUCCESSFUL TREATMENT OF PURE RED CELL APLASIA IN A CHILD BY HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN. 94
    G C Del Vecchio
    L Piacente
    D De Mattia
    F Schettini
    Pediatric Research, 1997, 41 (5) : 762 - 762
  • [43] Nitric oxide dependent modulation of inflammatory cytokine secretion in mammalian macrophages by intravenous immunoglobulin.
    Williams, MA
    Lewis, A
    Kelsey, SM
    Newland, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 107 - 107
  • [44] Adverse drug reactions related to intravenous immunoglobulin. Analysis of Bordeaux Pharmacovigilance Centre data
    Daveluy, A
    Miremont-Salame, G
    Moore, N
    Haramburu, F
    DRUG SAFETY, 2005, 28 (10) : 944 - 945
  • [45] Intravenous Immunoglobulin In The Trearment Of Severe Viral Pneumonia
    Choi, E.
    Park, S.
    Park, J.
    Huh, J.
    Lim, C. -M.
    Koh, Y.
    Chong, Y.
    Choi, S. -H.
    Hong, S. -B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [46] ANTICOMPLEMENTARY ACTIVITY AND THE SAFETY OF INTRAVENOUS IMMUNOGLOBULIN
    ROUSELL, RH
    BUDINGER, MD
    KEPPLER, DC
    VICTOR, R
    MINAGA, T
    CLINICAL THERAPEUTICS, 1989, 11 (01) : 143 - 150
  • [47] Pathogen safety and tolerability of intravenous immunoglobulin
    Rossi, F
    INTRAVENOUS IMMUNOGLOBULINS IN THE THIRD MILLENNIUM, 2004, : 399 - 404
  • [48] Safety of intravenous immunoglobulin (IVIG) therapy
    Katz, Uriel
    Achiron, Anat
    Sherer, Yaniv
    Shoenfeld, Yehuda
    AUTOIMMUNITY REVIEWS, 2007, 6 (04) : 257 - 259
  • [49] Viral safety of intravenous immunoglobulin: The view of the German regulatory agency, the Paul-Ehrlich Institute
    Schaffner, G
    INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 25 - 26
  • [50] High Dose Intravenous Immunoglobulin. The next step in therapy for severe COVID19 infection?
    Alejandra Mejia, Maria
    di Natale, Marisa
    Balastegui, Hector
    Gomez-Perez, Jimena
    Seoane, Elena
    Carbone, Javier
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S68 - S69